The Anabolic Properties of Fortified Plant-based Protein in Older People (Strongplant)
Muscle Protein Synthesis, Sarcopenia
About this trial
This is an interventional basic science trial for Muscle Protein Synthesis focused on measuring Muscle metabolism, Dietary protein, Plant protein
Eligibility Criteria
Inclusion Criteria: Male sex Aged between 60 and 75 y inclusive BMI between 18.5 and 30 kg/m2 Exclusion Criteria: Vegetarian and vegan diet Intolerant to milk products Soy allergy Pea allergy Participating in a structured (progressive) exercise program or >2.5h of vigorous physical activity per week. Smoking regularly (i.e. >5 cigarettes/week) Diagnosed GI tract disorders or diseases Diagnosed musculoskeletal disorders Diagnosed metabolic disorders (e.g. diabetes) Diagnosed with phenylketonuria (PKU) Hypertension (blood pressure above 140/90 mmHg) Donated blood 3 months prior to test day Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories). Chronic use of gastric acid suppressing medication Chronic use of anti-coagulants Recent (<1 year) participation in amino acid tracer studies (L-[ring-13C6]-phenylalanine and L-[3,5-2H2]-tyrosine)
Sites / Locations
- Maastricht University Medical Center+Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Fortified plant protein blend
Normal plant protein blend
Whey protein
20g of plant-based protein blend fortified with 2 g leucine
20g of plant-based protein blend
20g of whey protein